Neurofibrosarcoma-derived schwann cells overexpress platelet-derived growth factor (PDGF) receptors and are induced to proliferate by PDGF BE

被引:0
作者
Badache, A
De Vries, GH
机构
[1] Loyola Univ, Med Ctr, Dept Cell Biol Neurobiol & Anat, Chicago, IL 60611 USA
[2] Vet Affairs Edward Hines Jr Hosp, Hines, IL USA
关键词
D O I
10.1002/(SICI)1097-4652(199811)177:2<334::AID-JCP15>3.0.CO;2-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Neurofibromatosis type 1 (NF1) is characterized by the formation of neurofibromas, benign tumors of the peripheral nerve consisting essentially of Schwann cells, which can sometimes turn malignant to form neurofibrosarcomas. The mechanism of progression toward a malignant phenotype remains largely unknown. In this report, we show that platelet-derived growth factor (PDGF) BB, and to a lesser extent fibroblast growth factor 2, are mitogenic for two neurofibrosarcoma-derived Schwann cell lines, but not for a Schwann cell line derived from a schwannoma (from a non-NF1 patient) or for transformed rat Schwann cells. Levels of expression of both PDGF receptor alpha and beta are significantly increased in the two neurofibrosarcoma-derived cell lines compared to the non-NF1 Schwann cell lines. The level of tyrosyl-phosphorylated PDGF receptor beta is strongly increased upon stimulation by PDGF BE. In comparison, only modest levels of tyrosyl-phosphorylated PDGF receptor alpha are observed, upon stimulation by PDGF AA or PDGF BE. Accordingly, PDGF AA is only a weak mitogen for the neurofibrosarcoma-derived cells by comparison to PDGF BB. These results indicate that the mitogenic effect of PDGF BE for the neurofibrosarcoma-derived Schwann cell lines is primarily transduced by PDGF receptor beta. Neu differentiation factor beta, a potent mitogen for normal Schwann cells, was unable to stimulate proliferation of the transformed Schwann cell lines, due to a dramatic downregulation of the erbB3 receptor. Therefore, aberrant expression of growth factor receptors by Schwann cells, such as the PDGF receptors, could represent an important step in the process leading to Schwann cell hyperplasia in NF1. J. Cell. Physiol. 177:334-342, 1998. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:334 / 342
页数:9
相关论文
共 38 条
[1]   Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis [J].
Badache, A ;
Muja, N ;
De Vries, GH .
ONCOGENE, 1998, 17 (06) :795-800
[2]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[3]  
Buchanan JamesM., 1990, CONST POLITICAL ECON, V1, P1, DOI 10.1007/BF02393031
[4]   A MAJOR SEGMENT OF THE NEUROFIBROMATOSIS TYPE-1 GENE - CDNA SEQUENCE, GENOMIC STRUCTURE, AND POINT MUTATIONS [J].
CAWTHON, RM ;
WEISS, R ;
XU, GF ;
VISKOCHIL, D ;
CULVER, M ;
STEVENS, J ;
ROBERTSON, M ;
DUNN, D ;
GESTELAND, R ;
OCONNELL, P ;
WHITE, R .
CELL, 1990, 62 (01) :193-201
[5]   BENIGN NEUROFIBROMAS IN TYPE-1 NEUROFIBROMATOSIS (NF1) SHOW SOMATIC DELETIONS OF THE NF1 GENE [J].
COLMAN, SD ;
WILLIAMS, CA ;
WALLACE, MR .
NATURE GENETICS, 1995, 11 (01) :90-92
[6]   PLATELET-DERIVED GROWTH-FACTORS AND FIBROBLAST GROWTH-FACTORS ARE MITOGENS FOR RAT SCHWANN-CELLS [J].
DAVIS, JB ;
STROOBANT, P .
JOURNAL OF CELL BIOLOGY, 1990, 110 (04) :1353-1360
[7]   ABNORMAL REGULATION OF MAMMALIAN P21(RAS) CONTRIBUTES TO MALIGNANT-TUMOR GROWTH IN VONRECKLINGHAUSEN (TYPE-1) NEUROFIBROMATOSIS [J].
DECLUE, JE ;
PAPAGEORGE, AG ;
FLETCHER, JA ;
DIEHL, SR ;
RATNER, N ;
VASS, WC ;
LOWY, DR .
CELL, 1992, 69 (02) :265-273
[8]  
DUCATMAN BS, 1986, CANCER-AM CANCER SOC, V57, P2006, DOI 10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO
[9]  
2-6
[10]   EXPRESSION OF PLATELET-DERIVED GROWTH-FACTOR (PDGF) AND PDGF ALPHA-RECEPTORS AND BETA-RECEPTORS IN THE PERIPHERAL NERVOUS-SYSTEM - AN ANALYSIS OF SCIATIC-NERVE AND DORSAL-ROOT GANGLIA [J].
ECCLESTON, PA ;
FUNA, K ;
HELDIN, CH .
DEVELOPMENTAL BIOLOGY, 1993, 155 (02) :459-470